SAB Biotherapeutics names Lucy To as CFO

• SAB Biotherapeutics (NASDAQ:SABS) said it has named Lucy To as CFO, effective August 12.
• To has over 18 years of experience and was most recently the managing director in the Healthcare Investment Banking Group at Wells Fargo.

More on SAB Biotherapeutics

• SAB Biotherapeutics rebrands as SAB BIO; reaffirms full-year outlook
• Seeking Alpha’s Quant Rating on SAB Biotherapeutics
• Historical earnings data for SAB Biotherapeutics
• Financial information for SAB Biotherapeutics